Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Rowe

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
BMC Geriatrics|July 14, 2022
Characterising Australian memory clinics: current practice and service needs informing national service guidelinesSharon L Naismith, Johannes C Michaelian, Lee-Fay Low, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2015
Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with MenGlenn-Milo Santos, Phillip Coffin, Deirdre Santos, et al.
Neuroscience Letters|May 26, 2020
Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's diseaseBryant Lim, Christopher Fowler, Qiao-Xin Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 24, 2025
Multivariate models using NULISAseq and plasma p-tau217 for staging Alzheimer's diseaseJames D Doecke, Edwin Stage, Christopher Fowler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2012
Aβ amyloid, cognition, and APOE genotype in healthy older adultsYen Ying Lim, Kathryn A Ellis, David Ames, et al.
Vaccine|April 30, 2013
Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticleRichard L Shimp, Christopher Rowe, Karine Reiter, et al.
Journal of Clinical and Experimental Neuropsychology|January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
Journal of Alzheimer'S Disease : JAD|April 1, 2008
Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian populationMira Rimajova, Nat P Lenzo, Jing-Shan Wu, et al.
Alzheimer'S Research & Therapy|June 11, 2020
Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathologyAzhaar Ashraf, Nicholas J Ashton, Pratishtha Chatterjee, et al.
Brain : a Journal of Neurology|September 24, 2024
Plasma biomarkers in chronic single moderate-severe traumatic brain injuryGershon Spitz, Amelia J Hicks, Stuart J McDonald, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
BMC Geriatrics|July 14, 2022
Characterising Australian memory clinics: current practice and service needs informing national service guidelinesSharon L Naismith, Johannes C Michaelian, Lee-Fay Low, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2015
Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with MenGlenn-Milo Santos, Phillip Coffin, Deirdre Santos, et al.
Neuroscience Letters|May 26, 2020
Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's diseaseBryant Lim, Christopher Fowler, Qiao-Xin Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 24, 2025
Multivariate models using NULISAseq and plasma p-tau217 for staging Alzheimer's diseaseJames D Doecke, Edwin Stage, Christopher Fowler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2012
Aβ amyloid, cognition, and APOE genotype in healthy older adultsYen Ying Lim, Kathryn A Ellis, David Ames, et al.
Vaccine|April 30, 2013
Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticleRichard L Shimp, Christopher Rowe, Karine Reiter, et al.
Journal of Clinical and Experimental Neuropsychology|January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
Journal of Alzheimer'S Disease : JAD|April 1, 2008
Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian populationMira Rimajova, Nat P Lenzo, Jing-Shan Wu, et al.
Alzheimer'S Research & Therapy|June 11, 2020
Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathologyAzhaar Ashraf, Nicholas J Ashton, Pratishtha Chatterjee, et al.
Brain : a Journal of Neurology|September 24, 2024
Plasma biomarkers in chronic single moderate-severe traumatic brain injuryGershon Spitz, Amelia J Hicks, Stuart J McDonald, et al.
Pageof 10